Similarly, men in rural areas in New Zealand were found to be less likely to participate in prostate-specific antigen (PSA) screening and to be diagnosed with prostate cancer at a later stage than men in metropolitan areas [5]. This evidence concerns the gene KLK3 and prostate carcinoma.